Screener / SEC EDGAR /CIK 0001723128 /10-K filed Feb 27, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Amneal Pharmaceuticals, Inc. AMRX

Compare with peers Embed
Who owns AMRX

Institutional owners are on their way

13F data can be up to 45 days old

We read every 13F filing after each quarter ends. The owners of AMRX show here after the next update.

Institutional ownership

Institutional owners

13F data sets, SEC

Institutional owners are on their wayWe read every 13F filing after each quarter ends. The owners of AMRX show here after the next update.

Funds that hold AMRX

Mutual funds and ETFs, each from its own latest portfolio report. Funds report on their own quarter ends.

Form N-PORT, SEC

Fund holdings are on their wayWe read the funds' N-PORT reports after each quarter. The funds that hold AMRX show here after the next update.

Superinvestors holding AMRX

The investors followed on Tickdelta, from their latest 13F.

All investors

None of the followed investors held AMRX in their latest 13F.

13D filings: owners who may push for change

Owners of more than 5%

Schedule 13D, last year
Aug 12, 2026 13D/A 17.6%of AMRX's shares
Tushar Patel · 61.34M shares · event Aug 10, 2026
Item 4, purpose of the transaction:This Amendment No. 6 to Schedule 13D (this "Amendment No. 6") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 6, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the Issuer. Capitalized terms used but not defined in this Amendment No. 6 shall have the meanings set forth in the Schedule 13D.
Read the filing
Aug 12, 2026 13D/A 8.4%of AMRX's shares
Chirag Patel · 29.10M shares · event Aug 10, 2026
Item 4, purpose of the transaction:This Amendment No. 7 to Schedule 13D (this "Amendment No. 7") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 7, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the Issuer. Capitalized terms used but not defined in this Amendment No. 7 shall have the meanings set forth in the Schedule 13D.
Read the filing
Aug 12, 2026 13D/A 9.4%of AMRX's shares
Chintu Patel · 32.58M shares · event Aug 10, 2026
Item 4, purpose of the transaction:This Amendment No. 5 to Schedule 13D (this "Amendment No. 5") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 5, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the Issuer. Capitalized terms used but not defined in this Amendment No. 5 shall have the meanings set forth in the Schedule 13D.
Read the filing
Mar 26, 2026 13D/A 5.4%of AMRX's shares
Patel Dipan · 16.90M shares · event Dec 31, 2025
Item 4, purpose of the transaction:This Amendment No. 5 to Schedule 13D (this "Amendment No. 5") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 5, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the New Issuer. Capitalized terms used but not defined in this Amendment No. 5 shall have the meanings set forth in the Schedule 13D. Between November 14, 2024 and December 31, 2025, trusts controlled by the Reporting Person sold 6,924,729 shares of Class A Common Stock in open market transactions at prices per share between $7.74 and $12.42.
Read the filing

Sources

SEC's Form 13F data sets, each quarter; Form N-PORT data sets for the funds; Schedule 13D filings.

Also

Investors: the portfolios of the superinvestors followed here. Insider trades: what the company's own people bought and sold.

Work with it

Excel workbook · CSV

Next:Cash & buybacks
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.